Is it safe to use chlorpheniramine maleate during the second trimester of pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Chlorpheniramine Maleate Use in Second Trimester

Yes, chlorpheniramine maleate can be safely used during the second trimester of pregnancy when antihistamine therapy is necessary. 1

Evidence-Based Recommendation

Chlorpheniramine is specifically recommended by multiple guidelines as a preferred first-generation antihistamine during pregnancy based on its long safety record and extensive human observational data 2. The 2008 rhinitis guidelines explicitly state that "a sufficient amount of human observational data has now been accumulated to demonstrate safety for second-generation as well as first-generation antihistamines," with chlorpheniramine having been "previously been recommended as first-choice agents because of their observed safety and longevity of use" 1.

Key Safety Points

Timing considerations:

  • The most critical period for teratogenic concern is the first trimester during organogenesis 1
  • By the second trimester, organogenesis is complete, making chlorpheniramine use even safer
  • No antihistamine has been shown to be teratogenic in humans 2

Clinical practice:

  • Chlorpheniramine is "often chosen by clinicians in the U.K. when antihistamine therapy is necessary because of its long safety record" 2
  • Both first-generation and second-generation antihistamines show "excellent safety records and do not show a significant increase in congenital malformations when used during the first trimester" 1

Important Caveats

Sedation effects:

  • Chlorpheniramine causes sedation and anticholinergic side effects, which may affect maternal quality of life 2
  • Consider timing doses to minimize daytime sedation (e.g., 4-12 mg at night) 2

Alternative considerations:

  • Second-generation antihistamines (cetirizine, loratadine) are FDA Pregnancy Category B and may be preferred to avoid sedation 2
  • However, chlorpheniramine's longer track record makes it a reasonable first choice when sedation is tolerable

FDA labeling:

  • The drug label states "If pregnant or breast-feeding, ask a health professional before use" 3, which is standard precautionary language but does not contraindicate use

Practical Dosing

Standard dosing: 4-12 mg at bedtime or divided doses during the day 2

The evidence strongly supports chlorpheniramine use throughout pregnancy, including the second trimester, when maternal benefit justifies treatment. The second trimester carries even less theoretical risk than the first trimester since organogenesis is complete.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.